Pharmaceutical

ipx203-phase-iii-clinical-study

Others

Unveiling the Safety and Dosing Patterns of IPX203: Insights from a Phase III Clinical Study

Explore More...
Pharma News and Updates for GSK, Roche, and Owkin

GSK’s RSV Vaccine Clears Phase III Test in Adults; Roche’s Tecentriq for Adjuvant NSCLC; Owkin Bags $ 180 million from BMS; EU Approves Roche’s Mosunetuzumab; Dostarlimab Elicits Clinical Complete Response in dMMR Rectal Cancer; FDA Backs Bluebird’s CALD Gene Therapy; Takeda’s Dengue Fever Vaccine TAK-003; FDA Approves Dupilumab

pulmonary arterial hypertension

New Clinical Developments in the Pulmonary Arterial Hypertension Treatment Domain

Pharma News for CG Oncology, Amgen, Elevar, and GSK

CG Oncology Teams Up With Merck & BMS; Parse Biosciences Partners With Molecular Diagnostics Korea; Amgen’s Olpasiran; Elevar Therapeutics Announces Results of Rivoceranib; FDA Approves GSK’s Measles Vaccine; Sage & Biogen Reveals Postpartum Depression Trial Result

Epileptic Encephalopathy

Epidiolex vs Fintepla: Fight in Rare Epilepsies

Diabetic Retinopathy

Diabetic Retinopathy: The Hornet’s Nest of Diabetes Mellitus

Monkeypox Outbreak - Insights Into Epidemiology, Treatment, Prevention

Assessing the Growing Challenge of MONKEYPOX and How Pharma Companies are Responding?

Pharma News and Updates for BMS, Mirati, Roche, Dermavant, Merck

Bristol-Myers Squibb’s Opdivo Approval; Mirati’s KRAS-inhibitor Adagrasib; J&J and Legend Biotech’s CAR-T Carvykti Approval; Roche’s Glofitamab; Arena Pharma’s Etrasimod Phase 3 Trials; FDA Approves Dermavant’s Vtama; FDA Approves Novartis’ Cell Therapy; NICE Approves Merck’s Keytruda

Obstructive Sleep Apnea

Covering the Therapeutic Advancements in Obstructive Sleep Apnea Treatment Scenario

Dry AMD Emerging Therapies in Therapeutics Market Pegcetacoplan and Zimura

Dry AMD Market: Pegcetacoplan or Zimura, Which Therapy Will Dominate the Market?

Pharma News For Sanofi, Bayer, Innoviva

PTC Therapeutics’ Gene Therapy Upstaza; Sanofi and Regeneron’s Dupixent; Bayer CAR-T Collaboration with Atara; FDA Accepts Biohaven’s Zavegepant; AbbVie Files FDA Approval for ABBV-951; Innoviva to Acquire Entasis; FDA Orphan Drug Designation to XMT-2056; FDA Approves Azacitidine for Juvenile Myelomonocytic Leukemia

Developmental and Epileptic Encephalopathy

Evaluation of the Advancing Developmental and Epileptic Encephalopathy Treatment Pipeline

Pharma News and Analysis for BMS, Sandoz, and Pfizer

BMS Sells NY Biologics Plant; FDA Approves Mitsubishi Tanabe’s Radicava, Love Pharma Acquires MicroDoz; Sandoz Launches Generic of Roche’s Esbriet; Pfizer to Acquire Biohaven Pharma; eureKARE’s Cell and Gene Therapy CDMO; Atamyo’s LGMD Gene Therapies; FDA approves Eli Lilly’s Type 2 Diabetes Treatment

Abdominal-Aortic-Aneurysm-Treatment

Discovering the Latest Developments in the Rapidly Advancing Abdominal Aortic Aneurysm Treatment Landscape

AL Amyloidosis Therapeutics Market Outlook

Assessing How Emerging Therapies Will Transform the AL Amyloidosis Treatment Dynamics

Pharma News and Update for Incyte and Aptose

AstraZeneca’s Farxiga; Incyte’s Jakavi; FDA Fast Track Status to HM43239 for R/R AML; Idorsia’s Insomnia Drug Quviviq; EU Approves Kymirah For Follicular Lymphoma; Perrigo Acquires HRA Pharma; Janssen Submits Marketing Authorisation Application to EMA

food-allergy-treatment-landscape

Most Promising Therapies in the Food Allergy Treatment Market

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Days
loader